Cytogenetic Alterations In Prostate Cancer -- The Regulation Of Prostatic Growth -- Current Concepts Of Oncogenes In Prostate Cancer -- Tumour Suppressor Genes In Prostate Cancer -- The Use Of Differential Display Pcr For The Detection Of New Tumor Suppressor Genes In Prostate Cancer -- Molecular Alterations Associated With Prostate Cancer Development -- Dysfunction Of The Cell-Cell Adhesion Complex In Lethal Prostate Cancer -- Heparan Sulfate Proteoglycans And Prostate Cancer: A Conceptual Framework -- Androgen Receptor Mutations In Prostate Cancer -- Antiandrogen Binding To Androgen Receptors And The Consequences -- Expression Of The Mdr1 Gene In Prostate Carcinoma -- Human Prostate Cancer Progression Models And Therapeutic Intervention -- Tumor Angiogenesis: The Vegf Signalling System Is A Novel Target For Prostate Cancer Therapy -- Antimetastatic Approaches To Therapy Of Prostate Cancer -- Intermittent Androgen Supression: Rationale And Clinical Experience -- Resistance To Drug Therapy In Cancer: Gene Therapy Approaches To Overcome Anticancer Drug Resistance -- Psa Rt-Pcr: Current Status And Future Potential -- Special Aspects Of Psma And Psa Rt-Pcr For The Detection Of Disseminated Prostate Cells -- Molecular Forms Of Psa, Psa Density, Age-/Race-Specific Reference Ranges, And Psa Velocity -- Reverse Transcriptase-Polymerase Chain Reaction Assays Used For Molecular Staging Of Prostate Cancer Patients -- Concluding Remarks.